glp 1 agonist for pcos Efficacy of GLP-1 Receptor Agonists in Obese Women with PCOS" by Ellie Fischer glp-1 for pcos PCOS Patients
Description
Orforglipron from Eli Lilly is a non-peptide, small-molecule GLP-1 agonist designed as a once-daily oral pill
Both conditions activate the sympathetic nervous system, the fight-or-flight response
Despite these promising developments, GLP-1RAs are associated with side effects and high costs, contributing to variability in patient access
References Zheng, Y
Therapy in GLP-1 receptor agonist overdose is mainly supportive
